Anupama
Anupama Mehra
Assistant Manager – Content
New Delhi, Updated on Sep 10, 2020 10:02 IST

The Indian Institute of Integrative Medicine (IIIM) Jammu has announced that it is undertaking clinical trials of 3-4 formulations for developing a COVID-19 drug.

The Indian Institute of Integrative Medicine (IIIM) Jammu has announced that it is undertaking clinical trials of 3-4 formulations for developing a COVID-19 drug. The IIIM is also in the final stage of validating a new machine-less coronavirus diagnostics kit, that can help the country scale-up COVID-19 testing, a senior official said.

“For COVID-19, we are undergoing clinical trials. In collaboration with Ayush ministry and industry, we are involved in it. Three to four clinical trials are going in different plant species with regard to COVID-19 drugs on 3 to 4 formulations,” Director CSIR-Indian Institute of Integrative Medicine (IIIM), Dr. D Srinivasa Reddy, told PTI.

“If they (all the requisite trials) are successful, we can make medicines soon available”, Reddy said.

“We are definitely getting closer. So many research groups from across the world are giving their best to find treatment for COVID-19. Discovering new medicines is a very long and costly process”, he said.

The director said that repurposing already known drugs to treat COVID-19 patients is the best option under the present circumstances.

“Several academic and industry groups across the globe are continuously working. In India, in particular, the CSIR (Council of Scientific and Industrial Research) is a frontrunner in this direction”, he added.

“We started testing in the first week of April, in collaboration with Government Medical College (GMC), Jammu. We have completed over 40,000 samples till date. We are in the process of increasing the number of samples tested,” he said.

Read More:

Follow Shiksha.com for latest education news in detail on Exam Results, Dates, Admit Cards, & Schedules, Colleges & Universities news related to Admissions & Courses, Board exams, Scholarships, Careers, Education Events, New education policies & Regulations.
To get in touch with Shiksha news team, please write to us at news@shiksha.com

About the Author
author-image
Anupama Mehra
Assistant Manager – Content
"The pen is mightier than the sword". Anupama totally believes in this and respects what she conveys through it. She is a vivid writer, who loves to write about education, lifestyle, and governance. She is a hardcor Read Full Bio
qna

Comments